Publication

Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application

Sadremomtaz, A., Ali, A. M., Jouyandeh, F., Balalaie, S., Navari, R., Broussy, S., Mansouri, K., Groves, M. R. & Asghari, S. M., 5-Jun-2020, In : Signal transduction and targeted therapy. 5, 1, 4 p., 76.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Sadremomtaz, A., Ali, A. M., Jouyandeh, F., Balalaie, S., Navari, R., Broussy, S., ... Asghari, S. M. (2020). Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application. Signal transduction and targeted therapy, 5(1), [76]. https://doi.org/10.1038/s41392-020-0177-z

Author

Sadremomtaz, Afsaneh ; Ali, Ameena M ; Jouyandeh, Foroozan ; Balalaie, Saeed ; Navari, Razieh ; Broussy, Sylvain ; Mansouri, Kamran ; Groves, Matthew R ; Asghari, S Mohsen. / Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application. In: Signal transduction and targeted therapy. 2020 ; Vol. 5, No. 1.

Harvard

Sadremomtaz, A, Ali, AM, Jouyandeh, F, Balalaie, S, Navari, R, Broussy, S, Mansouri, K, Groves, MR & Asghari, SM 2020, 'Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application', Signal transduction and targeted therapy, vol. 5, no. 1, 76. https://doi.org/10.1038/s41392-020-0177-z

Standard

Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application. / Sadremomtaz, Afsaneh; Ali, Ameena M; Jouyandeh, Foroozan; Balalaie, Saeed; Navari, Razieh; Broussy, Sylvain; Mansouri, Kamran; Groves, Matthew R; Asghari, S Mohsen.

In: Signal transduction and targeted therapy, Vol. 5, No. 1, 76, 05.06.2020.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Sadremomtaz A, Ali AM, Jouyandeh F, Balalaie S, Navari R, Broussy S et al. Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application. Signal transduction and targeted therapy. 2020 Jun 5;5(1). 76. https://doi.org/10.1038/s41392-020-0177-z


BibTeX

@article{1c8d22e5e863442883ecd7174bc1ce0c,
title = "Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application",
author = "Afsaneh Sadremomtaz and Ali, {Ameena M} and Foroozan Jouyandeh and Saeed Balalaie and Razieh Navari and Sylvain Broussy and Kamran Mansouri and Groves, {Matthew R} and Asghari, {S Mohsen}",
year = "2020",
month = "6",
day = "5",
doi = "10.1038/s41392-020-0177-z",
language = "English",
volume = "5",
journal = "Signal transduction and targeted therapy",
issn = "2059-3635",
number = "1",

}

RIS

TY - JOUR

T1 - Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application

AU - Sadremomtaz, Afsaneh

AU - Ali, Ameena M

AU - Jouyandeh, Foroozan

AU - Balalaie, Saeed

AU - Navari, Razieh

AU - Broussy, Sylvain

AU - Mansouri, Kamran

AU - Groves, Matthew R

AU - Asghari, S Mohsen

PY - 2020/6/5

Y1 - 2020/6/5

U2 - 10.1038/s41392-020-0177-z

DO - 10.1038/s41392-020-0177-z

M3 - Article

VL - 5

JO - Signal transduction and targeted therapy

JF - Signal transduction and targeted therapy

SN - 2059-3635

IS - 1

M1 - 76

ER -

ID: 126795905